![Phosphorylated Tau Protein Blood Test Distinguishes Alzheimer's Disease from Other Neurological Disorders - molecular-diagnostics - mobile.Labmedica.com Phosphorylated Tau Protein Blood Test Distinguishes Alzheimer's Disease from Other Neurological Disorders - molecular-diagnostics - mobile.Labmedica.com](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2020-05-04/GMS-061B.jpg)
Phosphorylated Tau Protein Blood Test Distinguishes Alzheimer's Disease from Other Neurological Disorders - molecular-diagnostics - mobile.Labmedica.com
![New Blood Test Differentiates Neurodegeneration in Alzheimer's Disease From Other Dementias - Neuroscience News New Blood Test Differentiates Neurodegeneration in Alzheimer's Disease From Other Dementias - Neuroscience News](https://neurosciencenews.com/files/2023/01/dementia-blood-test-neurosinces-public.jpg)
New Blood Test Differentiates Neurodegeneration in Alzheimer's Disease From Other Dementias - Neuroscience News
![Liquid-liquid phase separation induces pathogenic tau conformations in vitro | Nature Communications Liquid-liquid phase separation induces pathogenic tau conformations in vitro | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-16580-3/MediaObjects/41467_2020_16580_Fig1_HTML.png)
Liquid-liquid phase separation induces pathogenic tau conformations in vitro | Nature Communications
![Blood test method may predict Alzheimer's protein deposits in brain | National Institutes of Health (NIH) Blood test method may predict Alzheimer's protein deposits in brain | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2020/20200302-tau.jpg)
Blood test method may predict Alzheimer's protein deposits in brain | National Institutes of Health (NIH)
![JCM | Free Full-Text | Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review JCM | Free Full-Text | Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review](https://www.mdpi.com/jcm/jcm-09-03452/article_deploy/html/images/jcm-09-03452-g001.png)
JCM | Free Full-Text | Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
![Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology](https://www.thelancet.com/cms/attachment/fb62bbc1-0fb8-4500-b04b-0c60dfc8ce0c/gr1a_lrg.jpg)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
![Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease | Nature Communications Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-15701-2/MediaObjects/41467_2020_15701_Fig1_HTML.png)
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease | Nature Communications
![Novel form of Alzheimer's protein found in spinal fluid indicates stage of the disease – Washington University School of Medicine in St. Louis Novel form of Alzheimer's protein found in spinal fluid indicates stage of the disease – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/alzheimers3-01-1-700x467.jpg)
Novel form of Alzheimer's protein found in spinal fluid indicates stage of the disease – Washington University School of Medicine in St. Louis
![Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes: Molecular Therapy Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes: Molecular Therapy](https://www.cell.com/cms/attachment/478a7c78-9b00-4914-ba87-f20cbe87becc/fx1_lrg.jpg)